The findings by Dr. Rutka and his colleagues that commerci ally available gentamicin/betamethasone drop s do enter the middl e eal' space through a pressure-equalizing tube and can be otot oxi c were uniqu e and significant.' However, it is important to note that these ears were not inflamed and that these patient s had no history of chroni c infect ion. It is also significant that these patient s had a severe underl ying vestibular disor der, which led to the deci sion to ablate the ves tibular dysfunction with gentami cin. It is weil known that hydropi c ears are more susceptible to the effec ts of gentamic in.
Bedside testing I agree with Dr. Rutk a' s statemen t that our bedside exa minations in the Un ited States are lackin g. Tests for head-shaking nystagmu s and osc illo psia are not performed on patient s who have chronic eal' disease at any point durin g the course of management. Ne vertheless, vertig o is an easily reco gni zed neurotologic symptom, and I believe that most otolog ists would not miss it, especially in patient s with chronic eal'dise ase and asevere degree of ataxia.
Even if the physician were to miss verti go, the patient would not. I agree that recovery of ves tibular funct ion does occur, eve n when it is caused by intentional abl ation , and that patient s can often co mpensate for a unilateral loss. But I believe that patient s who are bein g treated for chro nic eal' disease will report dizziness, eve n if the physician does not spec ifica lly ask them about it. I do not believe that patients merely assume that dizziness is part of a chro nic eal' process. Personally, I agre e with these stateme nts. As I mentione d in my ear lier argume nt, I do not use aminog lycosi de drops forchronic ear disease in my practice because I have the option of using quin olone drops, which are safe r and whic h have ju st as goo d a bacteriologic profile.
I do use some ototoxic dru gs, such as ge ntamicin and ace tic acid, in some cases whe n I have no goo d alterna tiveo But all of our practices are dynamic, and further research might persuade me to aband on these age nts altogether. For now, howe ver, their benefits still outwe igh their risks. Nev ertheless, I predict that the use of ototoxic drop s in the Unit ed States will continue to declin e.
